**Core Concept**
Uterine atony in the postpartum period is a condition characterized by inadequate uterine contractions, leading to excessive bleeding. Managing uterine atony requires effective uterotonic agents to stimulate uterine contractions.

**Why the Correct Answer is Right**
In cases of uterine atony, the primary goal is to stimulate uterine contractions to reduce bleeding. Methylergonovine (Methergine), administered intramuscularly, is a direct uterotonic agent that acts on alpha-adrenergic receptors to induce uterine contractions. Prostaglandin F2α (Hemabate) suppositories work by directly stimulating the myometrium to contract, promoting uterine tone. Misoprostol (Cytotec) suppositories also stimulate uterine contractions by acting on the prostaglandin E receptor. In contrast, Terbutaline, a beta-2 adrenergic agonist, has a paradoxical effect on the uterus, causing relaxation and inhibiting uterine contractions, thereby exacerbating uterine atony.

**Why Each Wrong Option is Incorrect**
**Option A:** Methylergonovine is a direct uterotonic agent that can be effective in treating uterine atony.
**Option B:** Prostaglandin F2α (Hemabate) suppositories directly stimulate uterine contractions, making them suitable for managing uterine atony.
**Option C:** Misoprostol (Cytotec) suppositories effectively stimulate uterine contractions, making them a suitable option for treating uterine atony.

**Clinical Pearl / High-Yield Fact**
In cases of uterine atony, always consider the potential effects of beta-2 agonists, such as Terbutaline, which can exacerbate the condition. Always opt for direct uterotonic agents like Methylergonovine or Prostaglandin F2α for effective management.

**✓ Correct Answer: D. Terbutaline administered intravenously. This is not a suitable agent for managing uterine atony due to its potential to relax the uterus and inhibit contractions.**